WHO pauses hydroxychloroquine trial over safety concerns
CORONAVIRUS | The World Health Organization has suspended testing the malaria drug hydroxychloroquine in Covid-19 patients due to safety concerns, WHO director-general Tedros Adhanom Ghebreyesus said on Monday.
The World Health Organization said on Monday that it has suspended its trial of the malaria drug hydroxychloroquine in Covid-19 patients due to safety concerns.
Verifying user
RM12.50 / month
- Unlimited access to award-winning journalism
- Comment and share your opinions on all our articles
- Gift interesting stories to your friends
- Tax deductable